June 20th 2025
The AI software reportedly facilitates ease of use and improved accuracy in fetal ultrasound evaluations.
Is Whole Body Imaging Warranted for Thrombocytopenia Caused by a COVID-19 Vaccine?
June 14th 2022In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.
New Study Points to Longer Duration of Axillary Lymphadenopathy After COVID-19 Vaccine
May 20th 2022While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.
Can Deep Learning Ultrasound Assessment be a Viable Option for Diagnosing Ovarian Cancer?
April 20th 2022A new study suggests that deep learning algorithms with multimodal ultrasound have comparable specificity and sensitivity to subjective expert assessment and use of the O-RADS classification to distinguish between benign and malignant ovarian tumors.
Is Handheld Ultrasound the 'New Stethoscope'?
March 2nd 2022In combination with cloud-based data infrastructure and artificial intelligence (AI) applications, handheld ultrasound devices may have the potential to significantly enhance efficiency for providers and contribute to improved patient outcomes.
Philips Expands Imaging Capabilities on Handheld Ultrasound Device
February 10th 2022In addition to newly added advances with hemodynamic assessment and obstetric measurements, Lumify also offers a B-line quantification tool and AI-enhanced algorithms that may bolster ultrasound lung imaging in severe COVID-19 cases.
COVID Vaccine Side Effects and Mammograms: What a New Study Reveals
February 8th 2022Emerging research suggests that mammograms should not be delayed for women who develop unilateral lymphadenopathy after receiving COVID-19 vaccines, and that follow-up imaging is unnecessary for patients who have no history of cancer or suspicious concurrent symptoms.
Proposed Algorithm for Axillary Ultrasound Evaluation in Breast Cancer Patients Seeks Middle Ground
November 5th 2021Investigators at Massachusetts General Hospital proposed an algorithm for appropriate axillary nodal imaging to better align with changes in treatment algorithms for axillary nodal disease in patients with breast cancer.
Understanding Breast Imaging Features of Transgender Women Is Key to Improving Care
September 9th 2021Feminizing hormone therapy may increase the risk of breast cancer in transgender women, a growing body of research suggests, underscoring a need for health care providers to understand the risks, breast imaging features, and health care needs of this demographic.